Company intelligence / Profile preview

Sepragen

Union City, California, United States

Ownership: Private
Development stage: Other

Overview

Sepragen does not develop its own therapeutics but provides innovative purification and chromatography equipment and patented processes used in manufacture of over 30 FDA-approved biological drugs, including those for vaccines (notably COVID-19), blood products, and specialty nutritionals; its systems enable rapid, large-scale biologic drug and vaccine manufacture and scale-up for major global pharma and nutrition customers[1][2][3].

Industry: Non-Drug Biotech

Partnerships

AbbvieAmgenGSKOctapharmaNovartisSanofiTakedaSerum InstituteBiocon

Beyond the preview

Go deeper on Sepragen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sepragen.

Explore the full profile